{"transactions":[{"id":1879406,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":113159,"kind":"person","name":"O'Gorman Cedric","position":1,"cik":"0001962179","reported_name":"O'Gorman Cedric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-05-24T13:00:22.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.18,"value":31800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Purchase prices range from $3.135 to $3.2096 per share, inclusive."}],"balance_after":10121,"source":{"system":"sec-edgar","filing":"0001213900-23-042554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023042554/ownership.xml","form_type":"4"}},{"id":2054487,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":113159,"kind":"person","name":"O'Gorman Cedric","position":1,"cik":"0001962179","reported_name":"O'Gorman Cedric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-13T22:54:59.000Z","date":"2023-01-06","kind":"grant","acquired":false,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in 16 equal quarterly installments commencing on April 6, 2023."}],"balance_after":400000,"derivative":{"exercise_price":3.29,"expiration_date":"2033-01-06","underlying":"Common stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-23-002871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023002871/ownership.xml","form_type":"4"}}]}